Literature DB >> 5026404

New evidence for an -andrenergic component in the sympathetic centres: centrally mediated decrease in sympathetic tone by L-dopa and its antagonism by piperoxane and yohimbine.

H Schmitt, S Fénard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5026404     DOI： 10.1016/0014-2999(72)90173-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  6 in total

1.  R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure.

Authors:  N E Andén; C Gomes; B Persson; G Trolin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

2.  Actions of levodopa on the blood pressure of conscious rabbits.

Authors:  D B Calne; J L Reid
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

3.  Plasmatic renin activity in patients treated with L-dopa and inhibitor of dopa decarboxylase (IDC).

Authors:  H Allain; J Van den Driessche; D Bentue-Ferrer; J M Reymann; D Pape; M Madigand
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

4.  Reduction of hypoxia-induced disturbances by previous treatment with benserazide and L-dopa in rats.

Authors:  F Boismare; M le Poncin; J P Belliard; L Hacpille
Journal:  Experientia       Date:  1975-10-15

5.  On the mechanism of action of clonidine: effects on single central neurones.

Authors:  C Anderson; T W Stone
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

6.  The use of bromocriptine for testing central dopaminergic reactivity.

Authors:  H Allain; J M Reymann; D Bentue-Ferrer; D Pape; J van den Driessche; O Sabouraud
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.